Aspire Private Capital LLC Purchases 21 Shares of McKesson Co. (NYSE:MCK)

Aspire Private Capital LLC raised its position in shares of McKesson Co. (NYSE:MCK) by 1.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,186 shares of the company’s stock after acquiring an additional 21 shares during the period. Aspire Private Capital LLC’s holdings in McKesson were worth $1,246,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Atomi Financial Group Inc. raised its stake in shares of McKesson by 24.8% in the fourth quarter. Atomi Financial Group Inc. now owns 1,072 shares of the company’s stock valued at $611,000 after acquiring an additional 213 shares during the period. Great Waters Wealth Management boosted its position in shares of McKesson by 188.8% during the fourth quarter. Great Waters Wealth Management now owns 2,871 shares of the company’s stock valued at $1,636,000 after buying an additional 1,877 shares during the period. Transform Wealth LLC grew its stake in shares of McKesson by 13.3% during the fourth quarter. Transform Wealth LLC now owns 23,828 shares of the company’s stock valued at $13,595,000 after buying an additional 2,798 shares during the last quarter. Segment Wealth Management LLC lifted its stake in shares of McKesson by 1.2% during the 4th quarter. Segment Wealth Management LLC now owns 31,628 shares of the company’s stock worth $18,025,000 after acquiring an additional 366 shares during the last quarter. Finally, Perpetual Ltd boosted its holdings in McKesson by 13.5% during the 4th quarter. Perpetual Ltd now owns 1,937 shares of the company’s stock valued at $1,104,000 after acquiring an additional 230 shares during the period. 85.07% of the stock is currently owned by institutional investors.

Insider Transactions at McKesson

In other news, EVP Leann B. Smith sold 579 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $572.79, for a total transaction of $331,645.41. Following the transaction, the executive vice president now directly owns 864 shares in the company, valued at $494,890.56. The trade was a 40.12 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 0.11% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. Robert W. Baird raised shares of McKesson from a “neutral” rating to an “outperform” rating and boosted their target price for the company from $531.00 to $688.00 in a research note on Thursday, November 7th. Mizuho started coverage on shares of McKesson in a research note on Wednesday, December 4th. They set a “neutral” rating and a $630.00 price target for the company. Deutsche Bank Aktiengesellschaft decreased their target price on McKesson from $623.00 to $579.00 and set a “buy” rating for the company in a research report on Wednesday, September 25th. Baird R W upgraded McKesson from a “hold” rating to a “strong-buy” rating in a research note on Thursday, November 7th. Finally, Evercore ISI increased their target price on shares of McKesson from $560.00 to $680.00 and gave the stock an “outperform” rating in a report on Thursday, November 7th. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $646.14.

McKesson Trading Down 1.2 %

Shares of NYSE MCK opened at $585.51 on Wednesday. The company has a 50 day simple moving average of $594.65 and a two-hundred day simple moving average of $561.08. McKesson Co. has a 12 month low of $464.42 and a 12 month high of $637.51. The stock has a market cap of $74.32 billion, a price-to-earnings ratio of 30.32, a PEG ratio of 1.28 and a beta of 0.52.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $7.07 earnings per share for the quarter, beating the consensus estimate of $6.88 by $0.19. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The company had revenue of $93.65 billion during the quarter, compared to analysts’ expectations of $89.33 billion. During the same period last year, the business earned $6.23 earnings per share. McKesson’s quarterly revenue was up 21.3% on a year-over-year basis. Analysts forecast that McKesson Co. will post 32.73 EPS for the current year.

McKesson Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Monday, December 2nd were given a dividend of $0.71 per share. The ex-dividend date of this dividend was Monday, December 2nd. This represents a $2.84 annualized dividend and a dividend yield of 0.49%. McKesson’s dividend payout ratio (DPR) is presently 14.71%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.